These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 10438702)

  • 1. Genes encoding tumor-specific antigens are expressed in human myeloma cells.
    van Baren N; Brasseur F; Godelaine D; Hames G; Ferrant A; Lehmann F; André M; Ravoet C; Doyen C; Spagnoli GC; Bakkus M; Thielemans K; Boon T
    Blood; 1999 Aug; 94(4):1156-64. PubMed ID: 10438702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sperm protein 17 (Sp17) in multiple myeloma: opportunity for myeloma-specific donor T cell infusion to enhance graft-versus-myeloma effect without increasing graft-versus-host disease risk.
    Chiriva-Internati M; Wang Z; Xue Y; Bumm K; Hahn AB; Lim SH
    Eur J Immunol; 2001 Aug; 31(8):2277-83. PubMed ID: 11477539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma.
    Van den Eynde B; Peeters O; De Backer O; Gaugler B; Lucas S; Boon T
    J Exp Med; 1995 Sep; 182(3):689-98. PubMed ID: 7544395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor lysate-specific cytotoxic T lymphocytes in multiple myeloma: promising effector cells for immunotherapy.
    Wen YJ; Min R; Tricot G; Barlogie B; Yi Q
    Blood; 2002 May; 99(9):3280-5. PubMed ID: 11964294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous humoral and cellular immune response against cancer-testis antigen NY-ESO-1: definition of human histocompatibility leukocyte antigen (HLA)-A2-binding peptide epitopes.
    Jäger E; Chen YT; Drijfhout JW; Karbach J; Ringhoffer M; Jäger D; Arand M; Wada H; Noguchi Y; Stockert E; Old LJ; Knuth A
    J Exp Med; 1998 Jan; 187(2):265-70. PubMed ID: 9432985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MAGE, BAGE and GAGE gene expression in human rhabdomyosarcomas.
    Dalerba P; Frascella E; Macino B; Mandruzzato S; Zambon A; Rosolen A; Carli M; Ninfo V; Zanovello P
    Int J Cancer; 2001 Jul; 93(1):85-90. PubMed ID: 11391626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is there any relationship between gene expression of tumor antigens and CD4+ T cells in multiple myeloma?
    Braga WM; da Silva BR; Alves VL; Bortoluzo AB; Atanackovic D; Colleoni GW
    Immunotherapy; 2014; 6(5):569-75. PubMed ID: 24896625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cancer germ-line genes MAGE-1, MAGE-3 and PRAME are commonly expressed by human myeloma cells.
    Pellat-Deceunynck C; Mellerin MP; Labarrière N; Jego G; Moreau-Aubry A; Harousseau JL; Jotereau F; Bataille R
    Eur J Immunol; 2000 Mar; 30(3):803-9. PubMed ID: 10741395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of cancer/testis antigens in sporadic medullary thyroid carcinoma: expression and humoral response to NY-ESO-1.
    Maio M; Coral S; Sigalotti L; Elisei R; Romei C; Rossi G; Cortini E; Colizzi F; Fenzi G; Altomonte M; Pinchera A; Vitale M
    J Clin Endocrinol Metab; 2003 Feb; 88(2):748-54. PubMed ID: 12574209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effector memory and central memory NY-ESO-1-specific re-directed T cells for treatment of multiple myeloma.
    Schuberth PC; Jakka G; Jensen SM; Wadle A; Gautschi F; Haley D; Haile S; Mischo A; Held G; Thiel M; Tinguely M; Bifulco CB; Fox BA; Renner C; Petrausch U
    Gene Ther; 2013 Apr; 20(4):386-95. PubMed ID: 22739387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of LAGE-1 and NY-ESO-1 expression in multiple myeloma patients to explore possible benefits of their homology for immunotherapy.
    de Carvalho F; Vettore AL; Inaoka RJ; Karia B; Andrade VC; Gnjatic S; Jungbluth AA; Colleoni GW
    Cancer Immun; 2011 Jan; 11():1. PubMed ID: 21247062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dickkopf-1 (DKK1) is a widely expressed and potent tumor-associated antigen in multiple myeloma.
    Qian J; Xie J; Hong S; Yang J; Zhang L; Han X; Wang M; Zhan F; Shaughnessy JD; Epstein J; Kwak LW; Yi Q
    Blood; 2007 Sep; 110(5):1587-94. PubMed ID: 17515399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The antigenic landscape of multiple myeloma: mass spectrometry (re)defines targets for T-cell-based immunotherapy.
    Walz S; Stickel JS; Kowalewski DJ; Schuster H; Weisel K; Backert L; Kahn S; Nelde A; Stroh T; Handel M; Kohlbacher O; Kanz L; Salih HR; Rammensee HG; Stevanović S
    Blood; 2015 Sep; 126(10):1203-13. PubMed ID: 26138685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term safety and activity of NY-ESO-1 SPEAR T cells after autologous stem cell transplant for myeloma.
    Stadtmauer EA; Faitg TH; Lowther DE; Badros AZ; Chagin K; Dengel K; Iyengar M; Melchiori L; Navenot JM; Norry E; Trivedi T; Wang R; Binder GK; Amado R; Rapoport AP
    Blood Adv; 2019 Jul; 3(13):2022-2034. PubMed ID: 31289029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a naturally processed NY-ESO-1 peptide recognized by CD8+ T cells in the context of HLA-B51.
    Jäger E; Karbach J; Gnjatic S; Jäger D; Maeurer M; Atmaca A; Arand M; Skipper J; Stockert E; Chen YT; Old LJ; Knuth A
    Cancer Immun; 2002 Sep; 2():12. PubMed ID: 12747757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytolytic T lymphocytes recognize an antigen encoded by MAGE-A10 on a human melanoma.
    Huang LQ; Brasseur F; Serrano A; De Plaen E; van der Bruggen P; Boon T; Van Pel A
    J Immunol; 1999 Jun; 162(11):6849-54. PubMed ID: 10352307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer-testis antigens: promising targets for antigen directed antineoplastic immunotherapy.
    Bodey B
    Expert Opin Biol Ther; 2002 Aug; 2(6):577-84. PubMed ID: 12171503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of five MAGE-A1 epitopes recognized by cytolytic T lymphocytes obtained by in vitro stimulation with dendritic cells transduced with MAGE-A1.
    Chaux P; Luiten R; Demotte N; Vantomme V; Stroobant V; Traversari C; Russo V; Schultz E; Cornelis GR; Boon T; van der Bruggen P
    J Immunol; 1999 Sep; 163(5):2928-36. PubMed ID: 10453041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer/testis antigen expression and specific cytotoxic T lymphocyte responses in non small cell lung cancer.
    Groeper C; Gambazzi F; Zajac P; Bubendorf L; Adamina M; Rosenthal R; Zerkowski HR; Heberer M; Spagnoli GC
    Int J Cancer; 2007 Jan; 120(2):337-43. PubMed ID: 17066423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Idiotype-specific cytotoxic T lymphocytes in multiple myeloma: evidence for their capacity to lyse autologous primary tumor cells.
    Wen YJ; Barlogie B; Yi Q
    Blood; 2001 Mar; 97(6):1750-5. PubMed ID: 11238117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.